- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Aplasia in Russian Federation
Total 75 results
-
Burnasyan Federal Medical Biophysical CenterUnknownNeutropenic Enterocolitis | Myeloablative Chemotherapy Induced Bone Marrow AplasiaRussian Federation
-
Federal Scientific Clinical Centre of Pediatric...Unknown
-
Federal Research Institute of Pediatric Hematology...RecruitingAcquired Aplastic AnemiaRussian Federation
-
Novartis PharmaceuticalsTerminatedAplastic AnemiaRussian Federation
-
National Research Center for Hematology, RussiaUnknownSeptic Shock | Nonchemotherapy Drug-induced Neutropenia | Neutropenia After Chemotherapy in Oncohematological Patients | Neutropenia in Patients With Aplastic AnemiaRussian Federation
-
State Budgetary Healthcare Institution, National...CompletedThe Impact of Virtual Reality on the Emotional State of Patients With Aphasia During Rehabilitation.Aphasia | Virtual Reality | Emotional DisturbancesRussian Federation
-
Federal Research Institute of Pediatric Hematology...UnknownInflammatory Myofibroblastic TumorRussian Federation
-
AstraZenecaCompletedHyperkalemia Elevated Plasma K+ Cardiovascular Disease (CVD)Russian Federation
-
State Scientific Centre of Coloproctology, Russian...UnknownCold Argon PlasmaRussian Federation
-
National Research Center for Hematology, RussiaUnknownLeukemia | Multiple MyelomaRussian Federation
-
St. Petersburg State Pavlov Medical UniversityActive, not recruiting
-
Ivan S MoiseevTerminated
-
CelgeneCompletedMultiple MyelomaRussian Federation
-
Shenzhen Geno-Immune Medical InstituteThe No.2 Clinical Hospital of the Ministry of HealthRecruitingMultiple Myeloma | PlasmacytomaChina, Russian Federation
-
Shenzhen Geno-Immune Medical InstituteThe No.2 Clinical Hospital of the Ministry of HealthRecruitingMultiple Myeloma or PlasmacytomaChina, Russian Federation
-
CelgeneCompletedMultiple MyelomaUkraine, Russian Federation
-
BiocadRecruitingMultiple MyelomaRussian Federation
-
Janssen Research & Development, LLCCompletedMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell NeoplasmUnited States, Belgium, Russian Federation
-
Janssen-Cilag International NVTerminatedMultiple MyelomaPoland, Turkey, Russian Federation, Hungary, Lithuania, Croatia, Germany
-
Novartis PharmaceuticalsActive, not recruitingAplastic AnemiaThailand, Russian Federation, Portugal, United Kingdom, Hong Kong, United States
-
Gilead SciencesTerminatedMultiple Myeloma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States, Czech Republic, Russian Federation
-
Oncopeptides ABTerminatedRelapsed Multiple Myeloma | Relapsed-Refractory Multiple MyelomaSerbia, Greece, Russian Federation, Czechia, Bulgaria, Georgia, Norway, Poland, Spain, Ukraine, Germany
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
InSightecCompletedMultiple Myeloma | Bone MetastasesUnited States, Canada, Israel, Italy, Russian Federation
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaKorea, Republic of, Russian Federation, Spain, Germany, Belgium, Denmark, Greece, France, United States, Ukraine, Poland
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, France, Spain, Israel, India, Romania, Korea, Republic of, Singapore, Russian Federation, Poland
-
TakedaRecruitingMultiple MyelomaRussian Federation
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
TauRx Therapeutics LtdTerminatedAlzheimer's Disease | Behavioral Variant Frontotemporal DementiaKorea, Republic of, United States, Spain, Taiwan, Canada, Belgium, Malaysia, United Kingdom, Australia, Singapore, Croatia, Finland, France, Germany, Netherlands, Romania, Russian Federation
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, Russian Federation, France, Korea, Republic of, Poland, Israel, Netherlands, Japan, Belgium, Greece, Switzerland, Australia, Austria, Brazil, Canada, China, Czechia, Italy, United Kingdom
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, United Kingdom, France, Korea, Republic of, Poland, Netherlands, Japan, Belgium, Greece, Australia, Austria, Brazil, Canada, China, Czechia, Israel, Italy, Russian Federation
-
AmgenCompletedMultiple MyelomaFrance, Poland, United Kingdom, Belgium, Germany, Spain, Israel, Serbia, Australia, Greece, Korea, Republic of, Russian Federation, Hungary, Sweden, Austria, Slovakia, Italy, Czechia, New Zealand
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
Janssen-Cilag Ltd.Legend BiotechCompletedMultiple MyelomaBelgium, United States, United Kingdom, Italy, Germany, Netherlands, Spain, France, Russian Federation, Poland
-
CelgeneCompletedMultiple MyelomaCanada, Denmark, Australia, Belgium, France, Germany, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom, Czechia, Greece
-
Janssen Research & Development, LLCActive, not recruitingA Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaMultiple MyelomaUnited States, Australia, France, United Kingdom, Germany, Israel, Turkey, Netherlands, Canada, Russian Federation, Czechia
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, France, Japan, Netherlands, Poland, Spain, Sweden, Greece, Canada, Korea, Republic of, Germany, Brazil, Israel, Mexico, Norway, Russian Federation
-
Janssen Research & Development, LLCTerminatedMultiple MyelomaCanada, United States, Belgium, Poland, Italy, France, Spain, Brazil, Russian Federation, Denmark, Greece, Germany, Netherlands
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Poland, United Kingdom, Belgium, Spain, Germany, Portugal, Bulgaria, Romania, Netherlands, Greece, Canada, Russian Federation, Hungary, Brazil, Slovakia, Czechia
-
Janssen Research & Development, LLCApproved for marketingMultiple MyelomaUnited States, United Kingdom, Spain, Brazil, Russian Federation, Japan
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Spain, Australia, Canada, United Kingdom, Italy, Switzerland, Bulgaria, Poland, Ukraine, Belgium, Germany, Hungary, Ireland, Israel, Russian Federation
-
AEterna ZentarisDana-Farber Cancer InstituteTerminatedMultiple MyelomaIsrael, Spain, Korea, Republic of, United States, Russian Federation, Canada, Ireland, Czechia, Slovakia
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, Poland, Ukraine, Germany, Spain, Turkey, Korea, Republic of, Brazil, Russian Federation, Netherlands, Hungary, Sweden, Czechia, Mexico
-
Oncopeptides ABTerminatedMultiple MyelomaUnited States, Austria, Belgium, Czechia, Denmark, Estonia, France, Greece, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom
-
pharmaand GmbHCompletedMultiple MyelomaCanada, Spain, United States, Czechia, Turkey, France, Sweden, Korea, Republic of, Thailand, Belgium, Greece, Germany, Hungary, Russian Federation, Italy, Poland, Australia, Lebanon, Portugal, Norway, Brazil, Netherlands
-
Celgene CorporationCompletedNewly Diagnosed Multiple MyelomaSpain, Netherlands, Austria, Australia, Italy, Russian Federation, United Kingdom, Israel, Belgium, Greece, Germany, Poland, Turkey, France, Denmark, Czech Republic, Belarus, Georgia, Ireland, Sweden, Switzerland, Ukraine
-
CelgeneCompletedMultiple MyelomaUnited States, Netherlands, Canada, Belgium, United Kingdom, Australia, Denmark, Germany, Spain, Switzerland, France, Italy, Greece, Russian Federation, Sweden, Czechia
-
Janssen Research & Development, LLCCompletedMultiple MyelomaCanada, United States, Czechia, Israel, Italy, Korea, Republic of, Brazil, United Kingdom, Japan, Taiwan, Australia, Poland, Spain, France, Russian Federation, Sweden, Ukraine, Greece
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden